View Article

  • A Comprehensive Review on the Phytochemistry, Pharmacology & Toxicity of Parthenium Hysterophorus

  • R. G. Sapkal College of Pharmacy, Anjaneri, Nashik.

Abstract

Parthenium hysterophorus (Asteraceae) is an invasive weed found across many parts of the world. It produces a wide variety of natural compounds that show both useful and harmful effects. This review brings together current information about its chemical makeup, medicinal potential, and toxic effects. The plant contains several active compounds, such as sesquiterpene lactones (parthenin), flavonoids, phenolic acids, alkaloids, and essential oils. Research so far through laboratory and animal studies, and a few clinical observations, suggests that Parthenium hysterophorus has many biological activities, including anti-inflammatory, antimicrobial, antioxidant, insecticidal, allelopathic, and even anticancer properties. However, the same plant is also known to be toxic to humans and animals, causing skin allergies, asthma, liver damage, and possible genetic effects. Its chemicals can also harm ecosystems by suppressing native plants and reducing crop yields. This review discusses both the potential benefits and risks of this plant, examines gaps and inconsistencies in existing research, and suggests areas for future study such as better toxicity testing, safer formulations, and improved management to prevent its spread. Overall, Parthenium hysterophorus is a plant with two faces: both a potential medicinal resource and a harmful invader that must be handled with caution.

Keywords

Parthenium hysterophorus, parthenin, phytochemistry, pharmacological activity, toxicity

Introduction

Traditional phytomedicines are the logical choice for primary health care for 80% of world’s population because of their affordable price and fewer side effect. Phytomedicines play a significant role for the treatment of various ailments along with boosting the immune system against pathology. The positive impact of herbs and plant species is due to the combined effects of their unique secondary metabolic processes. [1,2]

The Parthenium hysterophorus (Asteraceae) is commonly known as Congress plant, Carrot grass, Wild feverfew, Bitter weed, Star weed, and White top, and some call the plant “Scourge of India.” The Parthenium hysterophorus is a widely distributed invasive agricultural weed causing environmental threats. The major active chemicals present in parthenium are sesquiterpene lactones, mainly parthenin and phenolic groups, which also include caffeic, vanillic, ferulic, chlorogenic, and anisic acids, which are responsible for many plant species. [2]

Parthenium hysterophorus is a highly invasive ruderal annual weed that is rapidly spreading throughout Asia and other areas beyond its native range in the central region and South America and the southern USA with highly deleterious effects on native biodiversity, human & animal health, and pasture productivity. Parthenium hysterophorus has a short life cycle of 90 to 120 days. It can thrive under a wide range of weather conditions, germinating at temperatures ranging from 12°C to 27°C. It is also serving in an area of low humidity. [3]

The primary objective of this review is to provide a comprehensive analysis of the current state of knowledge regarding the phytochemistry, pharmacology, and toxicity of Parthenium hysterophorus. [4] By synthesizing findings from recent research, this review aims to identify key bioactive compounds, elucidate mechanisms of action, assess safety profiles, and highlight research gaps that need to be addressed for the safe and effective utilization of this plant's therapeutic potential. Despite its notorious reputation as a weed, Parthenium hysterophorus has attracted considerable scientific interest due to its complex phytochemical profile and diverse biological activities. The plant has been used in traditional medicine systems for treating various ailments, including fever, skin diseases, and digestive disorders. However, the same chemical constituents that confer therapeutic properties also contribute to significant toxicological concerns, creating a complex risk-benefit scenario that requires careful scientific evaluation. [4,5]

Figure 1. Morphology of Plant

Phytochemistry

 Parthenium contains primary metabolites & secondary metabolites dominated by sesquiterpene lactones, flavonoids, phenolic compounds, terpenes, and phytosterols. [6]

Primary and secondary metabolism:

Parthenium hysterophorus has common primary metabolites plus a wide array of secondary metabolites that explain its bioactivity and allelopathy. The phytochemistry survey report covers protein, amino acids, carbohydrates, and fix oil in primary metabolites & sesquiterpene lactones, flavonoids, phenolic, terpenoid sterols, and alkaloids. Primary metabolites are found in the root, stem, and leaves. [4, 7, 9]

Specific Compound Name:

The compound is present depending on the solvent extraction method, such as ethanol, methanol, hexane, benzene, chloroform, ethyl acetate, ethyl alcohol, and aqueous media & isolation method. 

1) Parthenin are present in the whole plant, and heir chemical class is pseudo guaianolide sesquiterpene lactone. [1, 2, 4, 6]2) Hysterolides-A are present in the whole plant, and their chemical class is dimeric/monomeric pseudo guaianolide lactone. It is a new compound found in the plant extraction process, and also some investigation is incomplete. [18]

3) 3-o-methylquercetin (ethyl acetate): Their chemical class is flavonoid. [7]

4) Chlorogenic acid, caffeic acid, ferulic acid, and quinic acid are all present in the leaf, flower, and stem (leaf>flower>stem) or leaf methanolic, and their chemical class is hydroxycinnamic/phenolic acid. [9, 10, 12]

5) 4-methoxybenzoic acid is a benzene derivative and is isolated by the acetyl acetate fraction. [9, 10]

6) Beta-sitosterol is isolated by petroleum ether or ethyl acetate, and their chemical name is phytosterols. [18]

Figure 2. Specific Compound

Table 1. Property And Use Of Compound

Compound Name

Compound Property

Compound uses

Parthenin

A sesquiterpene lactone is highly reactive & biologically active.

Exhibits antimicrobial, anti-inflammatory, anticancer properties.

Investigated for its anticancer activity.

Also serves as a lead compound for drug development.

Caffeic acid

A hydroxycinnamic acid; a potent antioxidant.

Exhibits anti-inflammatory, antiviral, and immunomodulatory activities.

 

Used in cosmetics and nutraceuticals for antioxidant protection.

Shows potential in preventing cardiovascular diseases and cancer.

Ambrosin

Another sesquiterpene lactone similar to parthenin.

Shows cytotoxic and anti-inflammatory effects.

Studied for its anticancer and antimicrobial activities.

Acts as an inhibitor of the NF-κB pathway

P-Coumaric acid

A phenolic compound with antioxidant and antimicrobial properties.

Protects against oxidative stress.

Used in food and pharmaceutical industries for preservation and protection.

Contributes to skin protection and UV-absorbing formulations.

Vanillic acid

A benzoic acid derivative with antioxidant, antimicrobial, and anti-inflammatory properties.

Used in flavoring agents, cosmetics, and pharmaceuticals.

Potential in treating liver and kidney disorders due to antioxidant effects.

Anisic acid

Has mild antiseptic and antioxidant activities.

Aromatic compound with a pleasant odor.

Employed in flavor and fragrance industries.

Intermediate in drug and dye synthesis.

Gallic acid

A trihydroxy benzoic acid; a strong antioxidant, antibacterial, and antiviral.

Used in pharmaceuticals, inks, and food preservatives.

Exhibits anticancer, anti-inflammatory, and neuroprotective potential.

Fumaric acid

A dicarboxylic acid with antioxidant and anti-inflammatory properties.

Used in food (as acidity regulator E297).

Fumarate esters are used in psoriasis treatment and as metabolic intermediates.

Ferulic acid

A hydroxycinnamic acid, powerful antioxidant and UV absorber.

Anti-aging and skin-protective compound.

Common in cosmetic creams for anti-aging.

Shows anticancer, anti-inflammatory, and cardioprotective effects.

Chlorogenic acid

An ester of caffeic acid and quinic acid; a potent antioxidant.

Exhibits antidiabetic, antihypertensive, and hepatoprotective effects.

Found in green coffee beans used for weight loss and metabolic health.

Applied in nutraceuticals and anti-aging formulations.

Plant part and extraction method: 

Organ?targeted chemical profiling demonstrates a strong organ dependence of compound abundance, and multiple solvent systems and chromatographic/spectrometric methods are used for recovery and identification. Studies compare root, stem, leaf, phyllary, and receptacle chemotypes and use solvents from polar (water, methanol, ethanol) to nonpolar (hexane, petroleum ether, dichloromethane, ethyl acetate) followed by chromatographic separation and MS/NMR structural work. [6, 14, 20]

Table 2. Extraction Of Parthenium Hysterophorus

Solvent & Method

Typical target compound recovery

Compound Analysis

Methanol /Ethanol

Phenolics, flavonoids, hydroxycinnamic acid, parthenin

HPLC-DAD, HPLC-MS, antioxidant assay.

Ethyle Acetate/

Dichloromethane

Terpenoids, flavonoids, sesquiterpene lactones

Column chromatography, NMR, single-crystal X-ray.

Petroleum ether/hexane

Nonpolar sterols, fatty acid, and hydrocarbons

GC-MS

Aqueous extracts

Polar phenolic and water-soluble constituents

liquid chromatography, bioassay

Structural conformation method

-

1D/2D NMR, MS, X-RD

Volatile terpenes (essential oil)

Germacrene-D, alpha-myrcene, trans-beta-ocimene, geraniol, beta-caryophyllene

E0 yield reported low (~0.04-0.05% W/W); sesquiterpenes are ~50% of oil composition in some reports.

Other small molecules

4-methoxybenzoic acid

Benzene derivatives and unique lactones were isolated and characterized.

Extraction yield and which compound predominates vary by solvent and organ. For example, leaf methanolic extract contains a higher total quantified phytochemical ppm than stem in one LC-MS/HPLC survey. And GC of leaves found phytol as a dominant peak. 

Pharmacological Activity

In pharmacological activity, experimental findings for antimicrobial, antioxidant, anti-inflammatory, cytotoxic, or anticancer and bioactivities with assay. Parthenium extract, fractions, and isolated compounds show in vitro antimicrobial, radical scavenging, and cytotoxic effects. Various studies used standard assays such as DPPH/TEAC/OH, hemolysis, cell-line cytotoxicity, and in vivo rodent models for quantity activity. The methanolic and ethanolic extracts are the main sources examined for cytotoxicity/anticancer, antimicrobial, antioxidant, and allelopathic activity of sesquiterpene lactones. [9, 11, 13]

Antimicrobial activity:

Crude and solvent extracts displayed antibacterial and antifungal activity in multiple screens; methanolic and n?hexane extracts showed inhibitory zones against bacterial isolates in published surveys, and reviews collate these antimicrobial reports across methodologies.

Specific MIC/MBC values are heterogenous across studies and not consistently reported; primary literature emphasizes extract?level activity rather than standardized MICs in many cases. [9,10]

Antioxidant activity:

Fractions of aqueous (Aq.) and ethanolic extracts (EE) were fractionated (vacuum liquid chromatography) and tested by TEAC, DPPH, and hydroxyl radical scavenging; several fractions produced significant radical scavenging and increased erythrocyte antioxidant enzymes (SOD and CAT) in vitro.

Reported IC50 examples: a methanolic whole?plant extract showed very low DPPH IC50 = 2.5 ± 0.05 μg/mL in one nutritional/biological study; flower methanolic extract showed DPPH IC50 ≈ 54.278 μg/µL (reported units in that study) with TPC and TFC values quantified by Folin and aluminium chloride assays. [17,20]

Anti?inflammatory activity:

Parthenin derivatives have been modified to reduce toxicity and retain anti?inflammatory efficacy; a dispiro?indanedione hybrid of parthenin (DIHP) reduced LPS?induced NO, TNF?α, IL?6, and IL?1β in macrophages and attenuated carrageenan paw edema and LPS?sepsis markers in mice, performing comparably to dexamethasone in those models.[13]

Cytotoxic / anticancer activity:

Isolated parthenin (compound 2 in an isolation study) exhibited cytotoxicity against SGC?7901, BEL?7402, K562, A549, and HeLa cell lines with IC50s of 8.9–14.4 μM depending on the line; cisplatin was used as a positive control in that comparison.

Reviews indicate potential anticancer leads but emphasize the need to separate efficacy from the inherent toxicity of pseudoguaianolide scaffolds. [7,9,13]

Other activities:

Larvicidal /insecticidal effects against mosquito larvae and aphids have been reported in experimental screens summarized by reviews, and essential oils/EO constituents contribute to insecticidal/larvicidal properties.

Nutritional element analyses report macro? and microelements (Ca, K, Na, Mg, Fe, Zn, and trace metals) in the plant but caution against using raw material because of toxic constituents.

Assay details and endpoints are available in the cited primary studies that used RP?HPLC?MS identification of phenolics, standard radical scavenging assays, and cell?based cytotoxicity screens. [13]

Mechanisms and safety:

Mechanistic data link sesquiterpene lactones and phenolics to observed bioactivities, while clinical and animal data document allergenicity and organ toxicity at higher doses. Experimental mechanistic studies indicate modulation of inflammatory signalling and antioxidant pathways, and fraction studies show enzyme modulation; toxicity studies document haematological and biochemical perturbations in vivo. [9]

  • Proposed mechanisms:
  1. Inflammation: Parthenin derivatives (DIHP) inhibit NF?κB and MAPK signalling and reduce proinflammatory mediators (NO, TNF?α, IL?6, IL?1β); DIHP also upregulates Nrf2 and antioxidant enzymes (SOD, CAT) in cell and mouse models, linking anti?inflammatory effects to both suppression of proinflammatory transcription factors and enhancement of antioxidant response.
  2. Antioxidant enzyme modulation: Selected aqueous fractions increased SOD activity, and both aqueous and ethanolic fractions increased CAT activity in erythrocyte assays, indicating direct or indirect enhancement of cellular antioxidant defences. [17]
  3. Cytotoxicity / Anticancer: Parthenin and related pseudo guaianolides likely exert cytotoxicity via electrophilic α?methylene?γ?lactone motifs that alkylate nucleophilic residues on proteins or DNA and disrupt cellular processes; isolated parthenin showed low?micromolar IC50s in cancer cell lines. [7,9]
  4. Allelopathy and allergenicity: Volatile terpenes and sesquiterpene lactones contribute to allelopathic phytotoxicity and human allergic contact dermatitis/airway sensitization reported in epidemiology and mechanistic reviews. [13]

Toxicity and safety data

  1. Human and livestock effects: Parthenium exposure is associated with allergic rhinitis, bronchitis, airborne contact dermatitis, and mutagenic concerns in population reports and reviews.
  2. Animal dosing study: Oral administration of flower crude extract to rabbits at 10, 20, 40, and 80 mg/kg for 10 days altered haematological, and biochemical parameters and produced histopathological indications of blood, liver and kidney toxicity in treated animals; hemolytic assays showed relatively low hemolysis thresholds for some extracts, and IC50 > 500 µg for hemolysis was reported for a methanolic flower extract in one study.
  3. In vitro hemolysis: Fractions from aqueous extract exhibited low cytotoxicity in hemolysis assays, whereas ethanolic fractions produced hemolytic effects in the same experimental series.
  4. Safety implication: The combination of allergenic sesquiterpene lactones and dose?dependent organ toxicity constrains therapeutic use of crude material; chemical modification (as with DIHP) and fractionation are strategies used to retain efficacy while reducing toxicity.

Where experimental concentrations and endpoints were reported, they are cited above from the primary studies (e.g., parthenin IC50s, rabbit dosing, DPPH IC50s) and should be consulted directly for full methodological details.

Toxicity of Parthenium hysterophorus

Parthenium hysterophorus contains abundant sesquiterpene lactones (notably parthenin), flavonoids, phenolic acids, and volatile terpenoids; extracts show antioxidant, antimicrobial, anti?inflammatory, and anti?HIV RT activity in vitro. Major safety concerns are allergic contact dermatitis, livestock toxicity, and cytotoxic/genotoxic effects of parthenin. Major chemical constituents and secondary metabolites

Parthenium’s chemistry is dominated by sesquiterpene lactones, diverse flavonoids, and phenolic acids, plus a complex essential?oil fraction; multiple solvent extracts recover different classes of metabolites. Below is a concise list of repeatedly reported compounds and, where available, quantitative notes. [21,22,23]

Table 3. Toxicity Of Parthenium Hysterophorus

Class

Representative compound

Reported concentration

Sesquiterpene lactones

Parthenin, ambrosian, hymen in

Parthenin is identified as the principal bitter or allelochemical and major SQL in many plant parts.

Flavonoids and Flavone Derivatives

Santin, luteolin,

Extensive list of flavonoids reported from leaves/flowers in phytochemical surveys.

Phenolic acid and simple phenol

Caffeic acid, chlorogenic acid, ferulic acid, and vanillic acid.

Phenolic acid reported across solvent extract

Essential oil terpenoid

Germacrene-D, myrcene, and geraniol.

Essential-oil yield from plant parts is typically low (~0.04-0.05% W/W), and oils are sesquiterpene-rich (~50%) and monoterpene-rich (~20%).

Sterols and other lipids

Stigmasterol, sitosterol.

Report in phytochemical overview

Miscellaneous

Histamine, alkaloids, cardiac glycoside, and triterpenes.

Detected variably depending on extraction and the plant’s part

Endophyte-derived metabolites

Anhydropseudophlegmacin-9,10-quinone derivatives

Reported from endophytic fungi or bacteria associated with Parthenium hysterophorus

Additional phytochemical details and extraction observations:

  • Extraction solvent and temperature markedly change the profile recovered; hexane/ethyl acetate/methanol/water extracts show different phytochemical fingerprints in thin?layer chromatography and spectrophotometric assays.
  • Endophytic microbes isolated from Parthenium produce secondary metabolites (e.g., anhydropseudophlegmacin derivatives) that may add to the plant’s bioactivity repertoire.
  • Quantitative essential oil yields and the high relative sesquiterpene content (~50%) are reported in multi?study compilations of oil analyses.

Biological activities and proposed mechanisms:

Parthenium extracts and isolated chemistry show several in vitro bioactivities and some in vivo effects for derivatives; most pharmacology is preclinical, and mechanisms are partially characterized. The opening paragraphs summarize key therapeutic directions and mechanistic evidence. [5,9]

  1. Antioxidant and radical?scavenging activity

Evidence: Crude methanolic leaf extracts showed strong DPPH scavenging with an IC50 of 2.5 ± 0.05 μg/mL (methanolic extract) compared with ascorbic acid 3.7 ± 0.03 μg/mL in one study. Spectrophotometric total antioxidant capacity and FRAP assays also indicated notable reducing power in multiple extracts.

  1. Antimicrobial and antiviral activities

Evidence: Hexane/ethyl acetate/methanol/water extracts inhibited bacterial pathogens in disc diffusion assays and showed broad antimicrobial activity in vitro. Silver nanoparticles synthesized with Parthenium leaf extract produced inhibition zones (at 80 mg/mL) of ~12–19 mm against clinical bacteria, including E. coli, P. aeruginosa, S. aureus, and others. Extracts also inhibited HIV?1 reverse transcriptase activity in biochemical assays.

  1. Anti?inflammatory and redox?modulating effects

Evidence and mechanism: A chemically modified derivative of parthenin (dispiro?indanedione hybrid, DIHP) demonstrated potent anti?inflammatory and antioxidant effects in macrophage LPS models and in vivo murine models; DIHP attenuated NO, TNF?α, IL?6, and IL?1β production, downregulated NF?κB and MAPK signalling, and upregulated Nrf2 and antioxidant enzymes (SOD, catalase) while reducing prostaglandin E2, leukotriene B4, and ROS; DIHP effects were comparable to dexamethasone in these models.

Interpretation: These data support an inflammation?modulating mechanism (NF?κB/MAPK inhibition plus Nrf2 activation) for a parthenin?derived molecule, but direct, well?characterized mechanisms for native parthenin remain incompletely defined.

  1. Anticancer and other proposed therapeutic properties

Evidence: Reviews and screening studies list anticancer, insecticidal, larvicidal, and hypoglycemic activities attributed to Parthenium constituents and essential oils and suggest the plant as a source for lead molecules; however, most evidence is preliminary (in vitro or rodent models) and requires further mechanistic and translational work.

Practical summary of evidence strength.

  1. Antioxidant: multiple in vitro assays with quantitative IC50/FRAP support activity.
  2. Antimicrobial /anti?HIV RT: in vitro biochemical and microbiological assays report inhibition, including specific assay results and inhibition zones.
  3. Anti?inflammatory: a parthenin derivative (DIHP) shows clear mechanism?level effects in vitro and in vivo via NF?κB/MAPK downregulation and Nrf2 upregulation.

Toxicity, dermatitis, and cytotoxicity concerns

  • Dermatitis and allergic disease

Parthenium is a major plant allergen and a leading cause of plant/contact dermatitis in affected regions; sesquiterpene lactones (SQLs) in trichomes, pollen, and dried plant powder are identified as the principal allergens causing airborne contact dermatitis, chronic actinic dermatitis, and widespread/exfoliative patterns in humans. Parthenin is repeatedly noted as a major SQL implicated in clinical parthenium dermatitis, although its role in direct phototoxicity is debated. [15,10]

  • Phototoxicity versus photo allergy

Conflicting reports exist: some authors report phototoxic/psoralen?type mechanisms and list psoralen?class compounds as culprits in phytophotodermatitis linked to Parthenium exposure, whereas established dermatology reviews emphasize SQLs (parthenin) as the main allergens and note that parthenin itself lacks well?documented phototoxicity; therefore, insufficient evidence exists to conclude that parthenin is phototoxic versus acting as a classic contact allergen. [20]

  • Cytotoxicity, mutagenicity, and livestock toxicity

Human/animal toxicity: Parthenin, hymenin, and ambrosin are repeatedly described as highly toxic allelochemicals and have been associated with mutagenic/clastogenic findings in the literature summarized by reviews.

Livestock effects: Fresh herbage and unprocessed plant material can be toxic to livestock; parthenin has been implicated in acute and chronic toxicity in animals and is the primary suspect compound for adverse effects after ingestion or exposure in grazing/herbage contexts. [10,11,18]

Experimental cytotoxicity: Reviews and biochemical characterizations Note cytotoxic and phytotoxic activities for SQLs and certain essential?oil fractions, but specific standardized LD50 or human exposure thresholds are not consistently reported across the surveyed literature.

  • Clinical and public?health implications

Dermatitis management and public health: High prevalence of parthenium dermatitis in parts of India and other endemic regions prompted clinical and public?health reviews emphasizing avoidance, awareness, and control measures because airborne exposure produces widespread morbidity. [4,12]

Safety summary: The plant contains potent biologically active and potentially genotoxic compounds; handling or use of crude material poses real safety risks.

  • Objective of work:
  1. To comprehensively summarize and published the evidence on the phytochemical constituents, pharmacological activity, and toxicity of parthenium hysterophorus.
  2. To evaluate the quality and reproducibility of pharmacological studies such as in vivo and in vitro studies.
  3. To synthesis human and animal toxicity reports.
  4. To identify propose prioritized future research direction, such as formulation, and mechanism of action studies.

Summary

Parthenium hysterophorus (Asteraceae) is a rapidly spreading weed that causes serious problems for the environment, agriculture, and human health across the world. Although it has long been known mainly as a harmful and allergenic plant, recent research has revealed that it also produces several active compounds, such as parthenin, sesquiterpene lactones, flavonoids, and phenolic substances, that may have useful medicinal properties alongside their toxic effects. A detailed review of its chemical composition, biological activities, and toxicity is therefore important to understand both its potential benefits and risks. This overview aims to bring together current findings on Parthenium hysterophorus, assess how its compounds might be used safely, and point out where more research is needed. Such insights can help guide scientists, healthcare professionals, and policymakers in exploring the plant’s possible use in medicine or agriculture while managing its harmful impacts.     

CONCLUSION

Parthenium hysterophorus is a widely distributed invasive weed that has gained scientific attention due to its diverse phytochemical constituents, particularly parthenin, which exhibits significant pharmacological potential. Numerous studies have demonstrated its anticancer, anti-inflammatory, antimicrobial, and antioxidant properties, suggesting that the plant could serve as a valuable source of bioactive compounds for drug development. However, its toxicity and allergenic effects pose serious health and environmental concerns, emphasizing the need for careful isolation, purification, and dose optimization of its active principles. Future research should focus on developing safe, standardized, and targeted formulations to harness the therapeutic potential of Parthenium hysterophorus while minimizing its toxic effects.

Future Perspective

  • Standardize cultivars or chemotype identification for reproducible phytochemical profiling.
  • Detailed pharmacokinetic and toxicokinetic studies of major compounds like parthenin in animal models.
  • Structure activity relationship works to find less-toxic analogues with retained bioactivity.
  • Controlled preclinical efficacy and safety studies for promising activities, e.g., anticancer, anti-inflammatory, etc.
  • Development of safe handling guidelines and public-health surveillance for occupational exposure in endemic regions.
  • Explore formulation approaches such as nanoencapsulation and targeted delivery to reduce toxicity while improving efficacy.

REFERENCES

  1. Pandey K, Sharma PK, Dudhe R. Anticancer activity of Parthenium hysterophorus Linn and Oldenlandia corymbosa Lam by Srb method. Sci. Rep. 2012;1(6):1-3.
  2. Kumar S, Mishra A, Pandey AK. Antioxidant mediated protective effect of Parthenium hysterophorus against oxidative damage using in vitro models. BMC complementary and alternative medicine. 2013 May 30;13(1):120.
  3. Lalita KA, Kumar A. Review on a weed Parthenium hysterophorus (L.). Int J Curr Res Rev. 2018 Sep;10(17):23-32.
  4. Jaiswal J, Singh N, Gupta VK, Doharey PK, Siddiqi NJ, Sharma B. Pharmacological chemistry and biomedical implications of chemical ingredients from Parthenium hysterophorus. Current Topics in Medicinal Chemistry. 2022 Sep 1;22(23):1950-65.
  5. Khaket TP, Aggarwal H, Jodha D, Dhanda S, Singh J. Parthenium hysterophorus in current scenario: A toxic weed with industrial, agricultural and medicinal applications. Journal of Plant Sciences. 2015 Mar 1;10(2):42.
  6. Roy A, Kumar PA. Review on the pharmacological properties and other aspects of Parthenium hysterophorus (L.). Journal of Survey in Fisheries Sciences. 2023;10(2S):1-5.
  7. Joshi A, Bachheti RK, Sharma A, Mamgain R. Parthenium hysterophorus. L.(asteraceae): a boon or curse? (a review). Oriental Journal of Chemistry. 2016;32(3):1283.
  8. Khan RA, Ahmed M, Khan MR, Yasir M, Muhammad B, Khan R. Nutritional investigation and biological activities of Parthenium hysterophorus. Afr. J. Pharm. Pharmacol. 2011 Nov 15; 5:2073-8.
  9. Bezuneh TT. Phytochemistry and antimicrobial activity of Parthenium hysterophorus L.: A review. Sci. J. Anal. Chem. 2015 Jun 25;3(3):30.
  10. Alfaro Jiménez MA, Zugasti Cruz A, Silva Belmares SY, Ascacio Valdés JA, Sierra Rivera CA. Phytochemical and Biological Characterization of the Fractions of the Aqueous and Ethanolic Extracts of Parthenium hysterophorus. Separations. 2022 Nov 9;9(11):359.
  11. Fazal HI, Ahmad N, Ullah I, Inayat H, Khan L, Abbasi BH. Antibacterial potential in Parthenium hysterophorus, Stevia rebaudiana and Ginkgo biloba. Pak. J. Bot. 2011 Apr 1;43(2):1307-13.
  12. Jaiswal J, Doharey PK, Singh R, Tiwari P, Singh N, Kumar A, Gupta VK, Siddiqui AJ, Sharma B. Biochemical Characterization of Different Chemical Components of Parthenium hysterophorus and Their Therapeutic Potential against HIV?1 RT and Microbial Growth. Biomed Research International. 2022;2022(1):3892352.
  13. Kumar S, Pandey S, Pandey AK. In vitro antibacterial, antioxidant, and cytotoxic activities of Parthenium hysterophorus and characterization of extracts by LC?MS analysis. BioMed Research International. 2014;2014(1):495154.
  14. Anwar W, Khan SN, Tahira JJ, Suliman R. Parthenium hysterophorus: an emerging threat for Curcuma longa fields of Kasur District, Punjab, Pakistan. Pakistan Journal of Weed Science Research. 2012 Mar 1;18(1).
  15. Niranjan A, Mishra S, Lehri A, Amla DV, Upadhyay RS, Nautiyal CS. Identification and quantification of heterologous compounds parthenin and organic acids in Parthenium hysterophorus L. using HPLC-PDA-MS-MS. Analytical Letters. 2013 Jan 1;46(1):48-59.
  16. Kumar S, Khandpu S, Rao DN, Wahaab S, Khanna N. Immunological response to Parthenium hysterophorus in Indian patients with Parthenium sensitive atopic dermatitis. Immunological investigations. 2012 Jan 1;41(1):75-86.
  17. Ahsan A, Farooq MA, Ahsan Bajwa A, Parveen A. Green synthesis of silver nanoparticles using Parthenium hysterophorus: optimization, characterization and in vitro therapeutic evaluation. Molecules. 2020 Jul 22;25(15):3324.
  18. Yadav N, Saha P, Jabeen S, Kumari S, Verma SK, Singh BS, Sinha MP. Effect of methanolic extract of Parthenium hysterophorus on haematological parameters in wistar albino rat. The Bioscan—International Journal of Life Sciences. 2010; 2:357-63.
  19. Khan A, Ali S, Khan M, Hamayun M, Moon YS. Parthenium hysterophorus’s endophytes: The second layer of defense against biotic and abiotic stresses. Microorganisms. 2022 Nov 9;10(11):2217.
  20. Kumar R, Kumar M, Srivastva S, Singh R, Sharma I. Role of Parthenium hysterophorus in Human Health, Agriculture and Sustainability of Ecosystem. Bio Science Research Bulletin-Biological Sciences. 2023 Jan 1;39(1).
  21. Panwar R, Sharma AK, Dutt D, Pruthi V. Phenolic acids from Parthenium hysterophorus: evaluation of bioconversion potential as free radical scavengers and anticancer agents. Advances in Bioscience and Biotechnology. 2015;6(01):11-7.
  22. Dutta A, Ash D, Roy A, Khamkat P, Ghosh A. Parthenium-Turmeric ointment: A novel approach for excision wound healing on rabbits. Research Journal of Pharmacy and Technology. 2022;15(1):293-300.
  23. Pandey K, Sharma PK, Dudhe R. Anticancer activity of Parthenium hysterophorus Linn and Oldenlandia corymbosa Lam by Srb method. Sci. Rep. 2012;1(6):1-3.

Reference

  1. Pandey K, Sharma PK, Dudhe R. Anticancer activity of Parthenium hysterophorus Linn and Oldenlandia corymbosa Lam by Srb method. Sci. Rep. 2012;1(6):1-3.
  2. Kumar S, Mishra A, Pandey AK. Antioxidant mediated protective effect of Parthenium hysterophorus against oxidative damage using in vitro models. BMC complementary and alternative medicine. 2013 May 30;13(1):120.
  3. Lalita KA, Kumar A. Review on a weed Parthenium hysterophorus (L.). Int J Curr Res Rev. 2018 Sep;10(17):23-32.
  4. Jaiswal J, Singh N, Gupta VK, Doharey PK, Siddiqi NJ, Sharma B. Pharmacological chemistry and biomedical implications of chemical ingredients from Parthenium hysterophorus. Current Topics in Medicinal Chemistry. 2022 Sep 1;22(23):1950-65.
  5. Khaket TP, Aggarwal H, Jodha D, Dhanda S, Singh J. Parthenium hysterophorus in current scenario: A toxic weed with industrial, agricultural and medicinal applications. Journal of Plant Sciences. 2015 Mar 1;10(2):42.
  6. Roy A, Kumar PA. Review on the pharmacological properties and other aspects of Parthenium hysterophorus (L.). Journal of Survey in Fisheries Sciences. 2023;10(2S):1-5.
  7. Joshi A, Bachheti RK, Sharma A, Mamgain R. Parthenium hysterophorus. L.(asteraceae): a boon or curse? (a review). Oriental Journal of Chemistry. 2016;32(3):1283.
  8. Khan RA, Ahmed M, Khan MR, Yasir M, Muhammad B, Khan R. Nutritional investigation and biological activities of Parthenium hysterophorus. Afr. J. Pharm. Pharmacol. 2011 Nov 15; 5:2073-8.
  9. Bezuneh TT. Phytochemistry and antimicrobial activity of Parthenium hysterophorus L.: A review. Sci. J. Anal. Chem. 2015 Jun 25;3(3):30.
  10. Alfaro Jiménez MA, Zugasti Cruz A, Silva Belmares SY, Ascacio Valdés JA, Sierra Rivera CA. Phytochemical and Biological Characterization of the Fractions of the Aqueous and Ethanolic Extracts of Parthenium hysterophorus. Separations. 2022 Nov 9;9(11):359.
  11. Fazal HI, Ahmad N, Ullah I, Inayat H, Khan L, Abbasi BH. Antibacterial potential in Parthenium hysterophorus, Stevia rebaudiana and Ginkgo biloba. Pak. J. Bot. 2011 Apr 1;43(2):1307-13.
  12. Jaiswal J, Doharey PK, Singh R, Tiwari P, Singh N, Kumar A, Gupta VK, Siddiqui AJ, Sharma B. Biochemical Characterization of Different Chemical Components of Parthenium hysterophorus and Their Therapeutic Potential against HIV?1 RT and Microbial Growth. Biomed Research International. 2022;2022(1):3892352.
  13. Kumar S, Pandey S, Pandey AK. In vitro antibacterial, antioxidant, and cytotoxic activities of Parthenium hysterophorus and characterization of extracts by LC?MS analysis. BioMed Research International. 2014;2014(1):495154.
  14. Anwar W, Khan SN, Tahira JJ, Suliman R. Parthenium hysterophorus: an emerging threat for Curcuma longa fields of Kasur District, Punjab, Pakistan. Pakistan Journal of Weed Science Research. 2012 Mar 1;18(1).
  15. Niranjan A, Mishra S, Lehri A, Amla DV, Upadhyay RS, Nautiyal CS. Identification and quantification of heterologous compounds parthenin and organic acids in Parthenium hysterophorus L. using HPLC-PDA-MS-MS. Analytical Letters. 2013 Jan 1;46(1):48-59.
  16. Kumar S, Khandpu S, Rao DN, Wahaab S, Khanna N. Immunological response to Parthenium hysterophorus in Indian patients with Parthenium sensitive atopic dermatitis. Immunological investigations. 2012 Jan 1;41(1):75-86.
  17. Ahsan A, Farooq MA, Ahsan Bajwa A, Parveen A. Green synthesis of silver nanoparticles using Parthenium hysterophorus: optimization, characterization and in vitro therapeutic evaluation. Molecules. 2020 Jul 22;25(15):3324.
  18. Yadav N, Saha P, Jabeen S, Kumari S, Verma SK, Singh BS, Sinha MP. Effect of methanolic extract of Parthenium hysterophorus on haematological parameters in wistar albino rat. The Bioscan—International Journal of Life Sciences. 2010; 2:357-63.
  19. Khan A, Ali S, Khan M, Hamayun M, Moon YS. Parthenium hysterophorus’s endophytes: The second layer of defense against biotic and abiotic stresses. Microorganisms. 2022 Nov 9;10(11):2217.
  20. Kumar R, Kumar M, Srivastva S, Singh R, Sharma I. Role of Parthenium hysterophorus in Human Health, Agriculture and Sustainability of Ecosystem. Bio Science Research Bulletin-Biological Sciences. 2023 Jan 1;39(1).
  21. Panwar R, Sharma AK, Dutt D, Pruthi V. Phenolic acids from Parthenium hysterophorus: evaluation of bioconversion potential as free radical scavengers and anticancer agents. Advances in Bioscience and Biotechnology. 2015;6(01):11-7.
  22. Dutta A, Ash D, Roy A, Khamkat P, Ghosh A. Parthenium-Turmeric ointment: A novel approach for excision wound healing on rabbits. Research Journal of Pharmacy and Technology. 2022;15(1):293-300.
  23. Pandey K, Sharma PK, Dudhe R. Anticancer activity of Parthenium hysterophorus Linn and Oldenlandia corymbosa Lam by Srb method. Sci. Rep. 2012;1(6):1-3.

Photo
Ashutosh Wagh
Corresponding author

R. G. Sapkal College of Pharmacy, Anjaneri, Nashik.

Photo
Jagruti Patil
Co-author

R. G. Sapkal College of Pharmacy, Anjaneri, Nashik.

Ashutosh Wagh*, Jagruti Patil, A Comprehensive Review on the Phytochemistry, Pharmacology & Toxicity of Parthenium Hysterophorus, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 11, 2145-2156 https://doi.org/10.5281/zenodo.17606805

More related articles
A Comparative Study of Anti-Microbial Potential of...
Pithani Aswini Devi, Gali Dhanalakshmi, Nakka Hemalatha, Panthaga...
Determination Of Etoricoxib By Analytical And Bioa...
Shweta Vinayak Rane, Sapan K. Shah, Dinesh R. Chaple, Mayur A. Lo...
Liposomal Gel Of Ciprofloxacin For Better Treatment Of Periodontal Disease...
Ekta Malik , Shubhangi Nema , Bharti Choudhary , Nazneen Dubey, ...
3D Printing in Pharmaceutical Technologies : A Review...
Abhisekh Sah, Suman Kumar Sanu, Sidra Tul Muntha Wazir , ...
Phytochemical and Pharmacological Insights into Ficus platyphylla and Ricinus co...
Chaithra K, Rishika H Menon, Ramya S, S Vidyasree, Sachin G, Ranjith Kumar P, ...
Related Articles
A Review on Moving Boundary Electrophoresis...
G. M. Srimyvizhiy, S. Abinaya, X. Marcelin Brigith, S. Thanikadevi, C. Thirupathi, V. Rajarajan, K. ...
More related articles
A Comparative Study of Anti-Microbial Potential of Ethanolic Extracts Obtained f...
Pithani Aswini Devi, Gali Dhanalakshmi, Nakka Hemalatha, Panthagada Sunitha, Vidani Krishna Veni, Sa...
Determination Of Etoricoxib By Analytical And Bioanalytical Methods: A Review...
Shweta Vinayak Rane, Sapan K. Shah, Dinesh R. Chaple, Mayur A. Lohi, Pooja R. Denge, Sahil D. Gayakw...
A Comparative Study of Anti-Microbial Potential of Ethanolic Extracts Obtained f...
Pithani Aswini Devi, Gali Dhanalakshmi, Nakka Hemalatha, Panthagada Sunitha, Vidani Krishna Veni, Sa...
Determination Of Etoricoxib By Analytical And Bioanalytical Methods: A Review...
Shweta Vinayak Rane, Sapan K. Shah, Dinesh R. Chaple, Mayur A. Lohi, Pooja R. Denge, Sahil D. Gayakw...